Self-Assembled Peptide Habitats to Model Tumor Metastasis.

cancer functionalisation hydrogel matrix peptide self-assembly

Journal

Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925

Informations de publication

Date de publication:
25 May 2022
Historique:
received: 26 04 2022
revised: 18 05 2022
accepted: 18 05 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 24 6 2022
Statut: epublish

Résumé

Metastatic tumours are complex ecosystems; a community of multiple cell types, including cancerous cells, fibroblasts, and immune cells that exist within a supportive and specific microenvironment. The interplay of these cells, together with tissue specific chemical, structural and temporal signals within a three-dimensional (3D) habitat, direct tumour cell behavior, a subtlety that can be easily lost in 2D tissue culture. Here, we investigate a significantly improved tool, consisting of a novel matrix of functionally programmed peptide sequences, self-assembled into a scaffold to enable the growth and the migration of multicellular lung tumour spheroids, as proof-of-concept. This 3D functional model aims to mimic the biological, chemical, and contextual cues of an in vivo tumor more closely than a typically used, unstructured hydrogel, allowing spatial and temporal activity modelling. This approach shows promise as a cancer model, enhancing current understandings of how tumours progress and spread over time within their microenvironment.

Identifiants

pubmed: 35735676
pii: gels8060332
doi: 10.3390/gels8060332
pmc: PMC9223161
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Australian Research Council
ID : DP130103131
Organisme : National Health and Medical Research Council
ID : GNT1144996

Références

Adv Mater. 2019 Sep;31(36):e1901166
pubmed: 31322299
Adv Mater. 2019 Mar;31(10):e1806899
pubmed: 30663123
Biomaterials. 2020 Feb;231:119667
pubmed: 31855625
Transl Oncol. 2017 Aug;10(4):578-588
pubmed: 28658650
Br J Cancer. 2009 Apr 21;100(8):1303-14
pubmed: 19367286
Adv Healthc Mater. 2020 Apr;9(7):e1901751
pubmed: 32134570
J Mater Chem B. 2014 Nov 28;2(44):7771-7778
pubmed: 32261914
Cell. 2018 Apr 5;173(2):515-528.e17
pubmed: 29625057
SLAS Discov. 2017 Jun;22(5):456-472
pubmed: 28520521
Mol Biol Cell. 1998 Aug;9(8):1969-80
pubmed: 9693360
J Biol Methods. 2016 Jul 24;3(3):e49
pubmed: 31453214
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Biomaterials. 2014 Feb;35(7):2264-71
pubmed: 24360576
Biopolymers. 2014 Mar;102(2):197-205
pubmed: 24488709
ACS Biomater Sci Eng. 2021 Jul 12;7(7):3340-3350
pubmed: 34125518
Adv Biosyst. 2019 Jan;3(1):e1800223
pubmed: 32627339
Biomaterials. 2019 Aug;213:119202
pubmed: 31132644
Cancer Lett. 2019 Oct 1;461:112-122
pubmed: 31325528
Int J Mol Sci. 2015 Mar 11;16(3):5517-27
pubmed: 25768338
Front Oncol. 2015 Apr 20;5:92
pubmed: 25941663
Biomaterials. 2010 Mar;31(7):1875-84
pubmed: 19926126
PLoS One. 2013 Dec 27;8(12):e84759
pubmed: 24386414
Nat Rev Cancer. 2018 Jan 25;18(2):65
pubmed: 29368744
Assay Drug Dev Technol. 2014 May;12(4):207-18
pubmed: 24831787
Cancer J. 2015 Jul-Aug;21(4):250-3
pubmed: 26222075
Int J Biochem Cell Biol. 2011 Apr;43(4):622-31
pubmed: 21216302
Biomaterials. 2019 Apr;198:37-48
pubmed: 30224090
Prog Polym Sci. 2012 Jan;37(1):106-126
pubmed: 22125349
PLoS One. 2013;8(3):e59689
pubmed: 23555746
Front Chem. 2019 Mar 27;7:172
pubmed: 31001512
Clin Chem. 2013 Jan;59(1):85-93
pubmed: 23193058
Cell Mol Life Sci. 2017 Aug;74(16):2999-3009
pubmed: 28401269
Biomaterials. 2005 Oct;26(30):5991-8
pubmed: 15878198
Pharmacol Ther. 2018 Apr;184:201-211
pubmed: 29097309
J Cell Mol Med. 2017 Jun;21(6):1073-1084
pubmed: 28276635
Phys Chem Chem Phys. 2017 May 17;19(19):12064-12074
pubmed: 28443878
PLoS One. 2015 Jun 25;10(6):e0130559
pubmed: 26110787
Oncotarget. 2017 Aug 5;8(40):66747-66757
pubmed: 28977993
Polymers (Basel). 2018 Jun 21;10(7):
pubmed: 30960615
Chem. 2019 Sep 12;5(9):2442-2449
pubmed: 31552305
Biotechnol Adv. 2014 Nov 15;32(7):1256-1268
pubmed: 25116894
Mol Cancer. 2014 Dec 11;13:263
pubmed: 25496021
J Cell Sci. 2010 Dec 15;123(Pt 24):4201-13
pubmed: 21123618
Macromol Biosci. 2019 Jan;19(1):e1800249
pubmed: 30324687
Chem. 2016 Aug 11;1(2):246-263
pubmed: 28393126
ACS Appl Mater Interfaces. 2022 Mar 16;14(10):12068-12076
pubmed: 35235309
Adv Healthc Mater. 2018 Mar;7(6):e1700980
pubmed: 29205942
Sci Rep. 2014 Oct 01;4:6468
pubmed: 25270048
Cell Signal. 2015 Feb;27(2):394-401
pubmed: 25435429
Acta Biomater. 2016 Jul 1;38:11-22
pubmed: 27131571
Biomaterials. 2010 Nov;31(32):8494-506
pubmed: 20709389
Hum Pathol. 1997 Nov;28(11):1230-6
pubmed: 9385927
Nanomedicine. 2016 Jul;12(5):1397-407
pubmed: 26961467
J Cell Sci. 1998 Jun;111 ( Pt 11):1535-44
pubmed: 9580561
Toxicol In Vitro. 2010 Jun;24(4):1314-23
pubmed: 20171269
Pancreatology. 2015 Jul;15(4 Suppl):S32-8
pubmed: 25845856
Int J Mol Sci. 2022 Apr 22;23(9):
pubmed: 35563037

Auteurs

Noora Al Balushi (N)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3000, Australia.

Mitchell Boyd-Moss (M)

School of Engineering, RMIT University, Melbourne, VIC 3000, Australia.
School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia.
BioFab3D, Aikenhead Centre for Medical Discovery, St. Vincent's Hospital, Fitzroy, Melbourne, VIC 3065, Australia.

Rasika M Samarasinghe (RM)

School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia.
Institute for Mental and Physical Health and Clinical Translation, Deakin University, Waurn Ponds, VIC 3216, Australia.

Aaqil Rifai (A)

School of Engineering, RMIT University, Melbourne, VIC 3000, Australia.
School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia.
Institute for Mental and Physical Health and Clinical Translation, Deakin University, Waurn Ponds, VIC 3216, Australia.

Stephanie J Franks (SJ)

Laboratory of Advanced Biomaterials, Research School of Chemistry and the John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.

Kate Firipis (K)

School of Engineering, RMIT University, Melbourne, VIC 3000, Australia.
BioFab3D, Aikenhead Centre for Medical Discovery, St. Vincent's Hospital, Fitzroy, Melbourne, VIC 3065, Australia.

Benjamin M Long (BM)

Future Regions Research Centre, Federation University Australia, Mount Helen, VIC 3353, Australia.

Ian A Darby (IA)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3000, Australia.

David R Nisbet (DR)

Laboratory of Advanced Biomaterials, Research School of Chemistry and the John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.
The Graeme Clark Institute, The University of Melbourne, Melbourne, VIC 3010, Australia.
Department of Biomedical Engineering, Faculty of Engineering and Information Technology, The University of Melbourne, Melbourne, VIC 3053, Australia.
Melbourne Medical School, Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, Melbourne, VIC 3010, Australia.

Dodie Pouniotis (D)

School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3000, Australia.

Richard J Williams (RJ)

School of Engineering, RMIT University, Melbourne, VIC 3000, Australia.
School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia.
BioFab3D, Aikenhead Centre for Medical Discovery, St. Vincent's Hospital, Fitzroy, Melbourne, VIC 3065, Australia.
Institute for Mental and Physical Health and Clinical Translation, Deakin University, Waurn Ponds, VIC 3216, Australia.

Classifications MeSH